It was in 2002-03 Christmas time when I suffered continuous gastrointestinal troubles. I’m a psychologist, a professional who, at that time, was very busy and, threatened by the idea of suffering cancer, I used to say that I did not have time enough to visit any...
News
Allen-Vercoe group publishes book chapter on Fusobacteria.
Graduate students Avery Robinson and Jacob Wilde contributed to a book chapter with Emma Allen-Vercoe that covers many aspects of Fusobacteria biology. Entitled "Fusobacteria: Physiology, Form and Function" it is published in "Colorectal neoplasia and the...
Avery Robinson and Greg Higgins awarded Canada Graduate Scholarships
Pop some champagne and toast Avery Robinson and Greg Higgins of the Allen-Vercoe lab! Avery won a Canada Graduate Scholarship - 3-year Doctoral Award, and Greg won a Canada Graduate Scholarship 1 year Master's award, both from the Canadian Institutes of Health...
Can we treat bowel cancer by targeting the bugs in our guts?
Bowel cancer Cancer refers to a collection of diseases in which some of the body’s cells divide uncontrollably and can spread to other parts of the body. Cancers can arise throughout the body but are generally divided into solid (e.g. bowel) or blood-based (e.g....
45 is the New 50
On October 27, 2020, the U.S. Preventive Services Task Force issued a recommendation that colorectal cancer screening of individuals at average risk for the disease start at age 45 rather than age 50. “This recommendation is hugely impactful,” said OPTIMISTICC...
Dr. Kimmie Ng on the death of “Black Panther” actor Chadwick Boseman and Young-Onset CRC
As a result of the tragic and untimely death of actor Chadwick Boseman from colorectal (CRC) cancer there has been increased awareness and attention to the alarming number of people being diagnosed with CRC under the age of...
IL-22 Pathway Identified as a New Target in Colon Cancers with Mutant KRAS
Work from Dr. Fiona Powrie’s group at University of Oxford has identified an interaction between the receptor for the immune molecule interleukin-22 (IL-22) and alterations of the KRAS gene, showing that they cooperate in promoting excessive proliferation of...
Co-Investigator and Advocate Dr. Laura Porter shares notes from the ASCO 2020 Virtual Meeting
I attended the virtual annual meeting of the American Society of Clinical Oncology (ASCO) May 29-31, 2020. I have attended multiple ASCO meetings, including the Annual Meeting and the Gastrointestinal ASCO meeting. Being a metastatic colon cancer survivor...
My Search for New BALOs
Bdellovibrio-and-Like Organisms (BALOs) are bacteria that have a unique lifestyle; they are predatory bacteria that attack and kill other bacterial species. The majority of the BALOs do this by squeezing inside the prey bacteria and using enzymes to dissolve the...
Biomarker for Locally Advanced Rectal Cancer (LARC) Identified from the Gut Microbiome
A team led by VHIO Principal Investigator and OPTIMISTICC scientist Dr. Paolo Nuciforo has found an association between the persistence of Fusobacterium nucleatum in rectal tumors of LARC patients after chemotherapy and higher rates of rectal cancer relapse....
Dr. Josep Tabernero receives National Research Award
Congratulations to Co-Investigator Josep Tabernero, MD, PhD, Director of Vall d’Hebron Institute of Oncology (VHIO), for receiving The National Research Award, bestowed by the Catalonian Government and the Catalonian Foundation for Research and...
Dr. Matthew Meyerson is an AACR Team Science Awardee
Congratulations to Co-Principal Investigator Matthew Meyerson, MD, PhD, who recently shared in the American Association for Cancer Research (AACR) 2020 Team Science Award for development of The Cancer Genome Atlas (TCGA)....